Heron Therapeutics (AXD2.STU) Q2 2026 Earnings

11MayConfirmed
Q2 2026
-0.03
-0.03
-0.02
-0.02

Details

Expected EPS
-0.01980948367
Actual EPS
-0.0339596
Surprise EPS
-0.01
Surprise Percent
+71.43%

Description

Heron Therapeutics (AXD2.STU) has reported earnings of -0.0339596 per share for Q2 2026.

0 Comments

Share your thoughts